161 related articles for article (PubMed ID: 38441657)
1. Developing a multivariable prediction model of global health-related quality of life in patients treated for rectal cancer: a prospective study in five countries.
Andersson J; Angenete E; Gellerstedt M; Haglind E
Int J Colorectal Dis; 2024 Mar; 39(1):35. PubMed ID: 38441657
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial.
Andersson J; Angenete E; Gellerstedt M; Angerås U; Jess P; Rosenberg J; Fürst A; Bonjer J; Haglind E
Br J Surg; 2013 Jun; 100(7):941-9. PubMed ID: 23640671
[TBL] [Abstract][Full Text] [Related]
4. Quality-of-life impairment after endoluminal locoregional resection and laparoscopic total mesorectal excision.
Lezoche E; Paganini AM; Fabiani B; Balla A; Vestri A; Pescatori L; Scoglio D; D'Ambrosio G; Lezoche G
Surg Endosc; 2014 Jan; 28(1):227-34. PubMed ID: 24002918
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
6. Surviving rectal cancer at the cost of a colostomy: global survey of long-term health-related quality of life in 10 countries.
Kristensen HØ; Thyø A; Emmertsen KJ; Smart NJ; Pinkney T; Warwick AM; Pang D; Elfeki H; Shalaby M; Emile SH; Abdelkhalek M; Zuhdy M; Poskus T; Dulskas A; Horesh N; Furnée EJB; Verkuijl SJ; Rama NJ; Domingos H; Maciel J; Solis-Peña A; Espín-Basany E; Hidalgo-Pujol M; Biondo S; Sjövall A; Christensen P
BJS Open; 2022 Nov; 6(6):. PubMed ID: 36546340
[TBL] [Abstract][Full Text] [Related]
7. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
8. The impact of bowel dysfunction on health-related quality of life after rectal cancer surgery: a systematic review.
Al Rashid F; Liberman AS; Charlebois P; Stein B; Feldman LS; Fiore JF; Lee L
Tech Coloproctol; 2022 Jul; 26(7):515-527. PubMed ID: 35239096
[TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation of health-related quality of life after laparoscopic colectomy for cancer.
Theodoropoulos GE; Karantanos T; Stamopoulos P; Zografos G
Tech Coloproctol; 2013 Feb; 17(1):27-38. PubMed ID: 23065134
[TBL] [Abstract][Full Text] [Related]
10. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
11. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in rectal cancer patients after radical surgery: a survey of Chinese patients.
Li X; Song X; Chen Z; Li M; Lu L; Xu Y; Zhan W; He Y; Xu K
World J Surg Oncol; 2014 May; 12():161. PubMed ID: 24886668
[TBL] [Abstract][Full Text] [Related]
13. Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.
El Alami Y; Essangri H; Majbar MA; Boutayeb S; Benamr S; El Malki HO; Souadka A
BMC Cancer; 2021 Jan; 21(1):99. PubMed ID: 33499819
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer.
Koole SN; Kieffer JM; K Sikorska ; Schagen van Leeuwen JH; Schreuder HWR; Hermans RH; de Hingh IH; van der Velden J; Arts HJ; van Ham MAPC; Aalbers AG; Verwaal VJ; Van de Vijver KK; Sonke GS; van Driel WJ; Aaronson NK
Eur J Surg Oncol; 2021 Jan; 47(1):101-107. PubMed ID: 31128948
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
[TBL] [Abstract][Full Text] [Related]
16. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of neoadjuvant chemoradiotherapy followed by sphincter-preserving resection on anal sphincter function in relation to quality of life among locally advanced rectal cancer patients: a cross-sectional analysis.
Ozgen Z; Ozden S; Atasoy BM; Ozyurt H; Gencosmanoglu R; Imeryuz N
Radiat Oncol; 2015 Aug; 10():168. PubMed ID: 26264590
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery.
Pucciarelli S; Del Bianco P; Toppan P; Serpentini S; Efficace F; Pasetto LM; Friso ML; De Salvo GL; Nitti D
Ann Surg Oncol; 2008 Jul; 15(7):1846-54. PubMed ID: 18459006
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial.
Coens C; Suciu S; Chiarion-Sileni V; Grob JJ; Dummer R; Wolchok JD; Schmidt H; Hamid O; Robert C; Ascierto PA; Richards JM; Lebbé C; Ferraresi V; Smylie M; Weber JS; Maio M; Bottomley A; Kotapati S; de Pril V; Testori A; Eggermont AMM
Lancet Oncol; 2017 Mar; 18(3):393-403. PubMed ID: 28162999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
